HOCH Health Ostschweiz

HOCH Health Ostschweiz is a research organisation in St. Gallen, Switzerland that has taken part in 8 EU-funded projects since 2008, receiving €5.0M in EU funding and leading 1 as coordinator.

EU funding received€5.0M
EU projects8
As coordinator1
Running now2
First EU project2008
Latest project2025
CountrySwitzerland
EU registration (PIC)999702080
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are HOCH Health Ostschweiz's own share of each project, not the project's full budget.

  • Horizon 2020€2.7M · 2 projects
  • FP7 (2007 to 2013)€2.3M · 5 projects
  • Horizon Europe€0 · 1 project

Projects

8 EU-funded projects, newest first. HOCH Health Ostschweiz led 1 of them as coordinator. Each links to the official record.

  • MDR-RAAssociated partner

    Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • CardiacStromaCoordinator

    Tissue Cytokines at the Nexus of Immune Cell-Cardiac Stromal Cell Interaction

    Horizon 2020 · 2022–2026 · Project on CORDIS ↗

    €2.4Mtheir share
  • HELICALPartner

    HEalth data LInkage for ClinicAL benefit

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €275ktheir share
  • DISCHARGEPartner

    Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

  • PEACHIPartner

    Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €562ktheir share
  • STROMAPartner

    Stromal Cell- Immune Cell Interactions in Health and Disease

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €505ktheir share
  • TOLERAGEPartner

    Normalisation of immune reactivity in old age – from basic mechanisms to clinical application

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €928ktheir share
  • OPCARE9Partner

    A European Collaboration to optimise research for the care of cancer patients in the last days of life

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €300ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • cardiovascular diseases
  • computed tomography
  • coronaviruses
  • data protection
  • data science
  • entrepreneurship
  • epidemiology
  • genetics
  • hepatitis C
  • immunology
  • inflammatory diseases
  • machine learning
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime